Topic
What else might GLP-1s treat?
Kidney disease, heart failure, sleep apnea, Alzheimer's, addiction and other emerging uses.
Microdosing Semaglutide: What's Actually KnownAbout one in seven GLP-1 users says they microdose, telehealth companies sell programs built around it, and there is not a single randomized trial showing it works.Microdosing Zepbound: What's Actually KnownNo randomized trial has ever tested intentional microdosing of tirzepatide. But 2026 brought three things that change the conversation: a US multi-dose pen, a randomized trial of dose reduction, and an FDA proposal to shut down compounded supply.Ozempic Babies: Semaglutide, Fertility and PregnancyUnplanned pregnancies on GLP-1 drugs are real, the likely mechanism is restored ovulation from weight loss, and the pregnancy safety data as of 2026 are cautiously reassuring but still limited.Semaglutide and Alcohol Cravings: What the Research ShowsThree randomized trials have now tested semaglutide for drinking, and the results are more encouraging than most people expect, though no GLP-1 drug is approved for alcohol use disorder.Semaglutide and Alzheimer's: What the EVOKE Trials FoundTwo of the largest Alzheimer's trials ever run tested oral semaglutide in 3,808 people and found no slowing of the disease, closing a hypothesis that observational studies had made look promising.Semaglutide for PCOS: What the Evidence Actually ShowsSemaglutide is not approved for polycystic ovary syndrome anywhere, but a growing set of small trials suggests it helps with weight, insulin resistance and menstrual cycles in women who also carry excess weight.Tirzepatide and Heart Failure: The SUMMIT Trial ExplainedSUMMIT was the first trial to show a drug could change the course of obesity-related heart failure with preserved ejection fraction. It cut heart failure events by 38 percent. It still did not produce an approved indication in the United States or Europe, and the reasons why are worth understanding.Tirzepatide for PCOS: What the Evidence Actually ShowsTirzepatide is not approved for polycystic ovary syndrome anywhere. One small randomized trial, a large real-world cohort and a newly launched phase 4 trial are the whole evidence base — and they point in a specific, limited direction.What Else Can Semaglutide Treat? Uses Beyond Weight LossA plain-English guide to everything semaglutide is FDA-approved to treat in 2026, what it is still being studied for, and which headline findings have not held up.What Else Can Tirzepatide Treat? Beyond Weight Loss and DiabetesTirzepatide has exactly four FDA-approved uses in the United States, split across two brand names. Everything else you have read about it — heart failure, fatty liver, PCOS, addiction, dementia — sits somewhere on a long ladder between a strong trial and a hopeful database study.Zepbound for Sleep Apnea: What the Evidence Actually ShowsZepbound is the first and only medication the FDA has approved for obstructive sleep apnea. The trial behind it is strong, the effect is large, and the two questions nobody can answer yet are whether it replaces CPAP and what happens if you stop.